Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02224625 · ClinicalTrials.gov registry record · Phase 3
Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth
A Phase 3 study, sponsored by Medline Industries.
- Completed
- Registry status
- Phase 3
- Development phase
- 249
- Enrollment target
NCT02224625 is a Phase 3 study that has completed, run by Medline Industries. The registered enrollment target is 249 participants.
The verdict
NCT02224625, a Phase 3 study, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 249 participants
- Enrollment target
Study Summary
Evaluating the irritation properties of CHG cloth. Some Subjects will also have the product applied to see if they become sensitized to repeated applications.
Interventions
- OTHER Saline
- DRUG Active Comparator
- DRUG 2% CHG Cloth solution
- DEVICE Vehicle Cloth
- OTHER SLS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02224625
The ClinicalTrials.gov registry entry for NCT02224625 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 249 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Saline is the first listed.
NCT02224625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02224625 about?
NCT02224625 is a clinical study titled "Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth". Evaluating the irritation properties of CHG cloth. Some Subjects will also have the product applied to see if they become sensitized to repeated applications.
What is the current status of trial NCT02224625?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 249 participants. The study started on 2014-08. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02224625?
The interventions under investigation include: Saline (OTHER), Active Comparator (DRUG), 2% CHG Cloth solution (DRUG), Vehicle Cloth (DEVICE), SLS (OTHER).
Who is sponsoring clinical trial NCT02224625?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.